Detalles de la búsqueda
1.
mRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challenge
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-428136
2.
Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle Vaccine
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-477915
3.
Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-440647
4.
The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-424729
5.
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-145920
6.
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-465542
7.
Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-456015
8.
Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-445189
9.
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-479037
Resultados
1 -
9
de 9
1
Próxima >
>>